Applied Therapeutics (APLT) Stock Statistics & Valuation Metrics

Applied Therapeutics has a market cap or net worth of $43.24M. The enterprise value is $1.13B.

Applied Therapeutics has 116.36M shares outstanding. The number of shares has decreased by -2.65% in one year.

Applied Therapeutics’s return on equity (ROE) is -1.85 and return on invested capital (ROIC) is 0.00%.

The current PE Ratio of Applied Therapeutics is -1.13. Applied Therapeutics’s PEG ratio is 0.02.

In the last 12 months, Applied Therapeutics had revenue of -$211.00K and earned -$187.31M in profits. Earnings per share was -$6.84.

In the last 12 months, operating cash flow was -$81.84M and capital expenditures $0.00, giving a free cash flow of -$81.84M billion.

Applied Therapeutics pays an annual dividend of , resulting in a dividend yield of

Applied Therapeutics upcoming earnings date is May 8, 2025, Before Open.

Applied Therapeutics as a current ratio of 3.06, with Debt / Equity ratio of 0.05

In the past 12 months, Applied Therapeutics has paid -$11.68M in taxes.

Applied Therapeutics EV to EBITDA ratio is -0.41, with an EV/FCF ratio of -0.51.

Applied Therapeutics has $98.87M in cash and marketable securities with $1.97M in debt, giving a net cash position of -$96.90M billion.

Gross margin is 100.00%, with operating margin of -22922.86%, and net profit margin of -23214.07%.

The average price target for Applied Therapeutics is $2.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy